Simplex Trading, LLC Sage Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$3.35 Billion
Q1 2024

A detailed history of Simplex Trading, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 37,954 shares of SAGE stock, worth $409,144. This represents 0.02% of its overall portfolio holdings.

Number of Shares

37,954

Previous 7,455 409.11%

Holding current value

$409,144

Previous $161,000 341.61%

% of portfolio

0.02%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$18.62 - $26.95 $567,891 - $821,948	30,499 Added 409.11%	37,954 $711,000
Q4 2023 Feb 02, 2024	BUY	$17.1 - $22.26 $127,480 - $165,948	7,455 New	7,455 $161,000
Q2 2023 Aug 04, 2023	BUY	$40.65 - $59.54 $104,145 - $152,541	2,562 New	2,562 $120,000
Q2 2022 Aug 03, 2022	SELL	$27.52 - $37.99 $126,839 - $175,095	-4,609 Reduced 21.02%	17,320 $559,000
Q1 2022 May 02, 2022	BUY	$30.71 - $45.71 $495,843 - $738,033	16,146 Added 279.2%	21,929 $725,000

Q4 2021 Feb 23, 2022	SELL	$37.06 - $47.11 $255,565 - $324,870	-6,896 Reduced 54.39%	5,783 $246,000
Q3 2021 Oct 28, 2021	BUY	$40.26 - $57.37 $322 - $458	8 Added 0.06%	12,679 $727,000
Q2 2021 Aug 12, 2021	SELL	$54.88 - $79.29 $1.25 Million - $1.81 Million	-22,802 Reduced 64.28%	12,671 $719,000
Q1 2021 Apr 26, 2021	BUY	$70.65 - $96.76 $2.24 Million - $3.07 Million	31,751 Added 853.06%	35,473 $2.66 Million
Q4 2020 Feb 02, 2021	BUY	$58.41 - $89.06 $153,443 - $233,960	2,627 Added 239.91%	3,722 $321,000
Q3 2020 Oct 14, 2020	BUY	$41.13 - $62.45 $45,037 - $68,382	1,095 New	1,095 $66,000
Q2 2020 Jul 13, 2020	SELL	$25.95 - $43.15 $279,715 - $465,113	-10,779 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$26.15 - $77.24 $281,870 - $832,569	10,779 New	10,779 $309,000
Q4 2019 Feb 05, 2020	SELL	$60.18 - $154.77 $218,573 - $562,124	-3,632 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$140.29 - $189.96 $198,370 - $268,603	1,414 Added 63.75%	3,632 $509,000
Q2 2019 Jul 26, 2019	BUY	$157.85 - $183.09 $350,111 - $406,093	2,218 New	2,218 $406,000
Q4 2018 Jan 16, 2019	SELL	$81.94 - $139.71 $204,768 - $349,135	-2,499 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$138.11 - $169.04 $159,655 - $195,410	-1,156 Reduced 31.63%	2,499 $352,000
Q2 2018 Jul 30, 2018	BUY	$140.36 - $175.76 $467,679 - $585,632	3,332 Added 1031.58%	3,655 $572,000
Q1 2018 Apr 26, 2018	SELL	$152.15 - $192.33 $127,501 - $161,172	-838 Reduced 72.18%	323 $52,000
Q4 2017 Jan 10, 2018	SELL	$60.72 - $167.34 $1.26 Million - $3.48 Million	-20,777 Reduced 94.71%	1,161 $191,000
Q3 2017 Oct 25, 2017	BUY	$61.4 - $88.52 $1.35 Million - $1.94 Million	21,938	21,938 $1.37 Million

Others Institutions Holding SAGE

# of Institutions

222

Shares Held

52.7M

Call Options Held

207K

Put Options Held

191K

View Full List

About Sage Therapeutics, Inc.

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

More about SAGE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Sage Therapeutics, Inc. Transaction History